These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26367070)

  • 61. Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?
    Kauffman MA; Morón DG; Sandoval G; Sica RE; Garcea O; Villa AM
    Medicina (B Aires); 2007; 67(5):436-8. PubMed ID: 18051225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children.
    Boiko AN; Guseva ME; Guseva MR; Boiko SY; Sudomoina MA; Bikova OV; Maslova OI; Favorova OO; Gusev EI
    J Neurovirol; 2000 May; 6 Suppl 2():S152-5. PubMed ID: 10871804
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Leukocyte Telomere Length Predicts Severe Disability in Relapsing-Remitting Multiple Sclerosis and Correlates with Mitochondrial DNA Copy Number.
    López-Armas GDC; Ramos-Márquez ME; Navarro-Meza M; Macías-Islas MÁ; Saldaña-Cruz AM; Zepeda-Moreno A; Siller-López F; Cruz-Ramos JA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674427
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HLA-DRB1*0101 is associated with the genetic susceptibility to develop lichen planus in the Mexican Mestizo population.
    Luis-Montoya P; Yamamoto-Furusho JK; Vega-Memije E; Rodríguez-Carreón A; Ruiz-Morales JA; Vargas-Alarcón G; Domínguez-Soto L; Granados J
    Arch Dermatol Res; 2007 Oct; 299(8):405-7. PubMed ID: 17665209
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients.
    Kaimen-Maciel DR; Reiche EM; Borelli SD; Morimoto HK; Melo FC; Lopes J; Dorigon RF; Cavalet C; Yamaguchi EM; Silveira TL; Da Silva WV; Comini-Frota ER; Brum Souza DG; Donadi EA
    Mol Med Rep; 2009; 2(6):993-8. PubMed ID: 21475933
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
    Lopez de Lapuente A; Pinto-Medel MJ; Astobiza I; Alloza I; Comabella M; Malhotra S; Montalban X; Zettl UK; Rodríguez-Antigüedad A; Fernández O; Vandenbroeck K
    Mult Scler; 2015 Oct; 21(12):1498-512. PubMed ID: 25623250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.
    Kappos L; Gold R; Arnold DL; Bar-Or A; Giovannoni G; Selmaj K; Sarda SP; Agarwal S; Zhang A; Sheikh SI; Seidman E; Dawson KT
    Mult Scler; 2014 Feb; 20(2):243-52. PubMed ID: 24150779
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis.
    Manna I; Liguori M; Valentino P; Condino F; La Russa A; Clodomiro A; Nisticò R; Di Palma G; Quattrone A
    J Neurol Sci; 2008 Jan; 264(1-2):112-7. PubMed ID: 17854833
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
    Liggett T; Melnikov A; Tilwalli S; Yi Q; Chen H; Replogle C; Feng X; Reder A; Stefoski D; Balabanov R; Levenson V
    J Neurol Sci; 2010 Mar; 290(1-2):16-21. PubMed ID: 20064646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The HLA-DR13 haplotype is associated with "benign" multiple sclerosis in northeast Italy.
    Perini P; Tagliaferri C; Belloni M; Biasi G; Gallo P
    Neurology; 2001 Jul; 57(1):158-9. PubMed ID: 11445652
    [No Abstract]   [Full Text] [Related]  

  • 72. PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.
    Pawlak-Adamska E; Nowak O; Karabon L; Pokryszko-Dragan A; Partyka A; Tomkiewicz A; Ptaszkowski J; Frydecka I; Podemski R; Dybko J; Bilinska M
    J Neuroimmunol; 2017 Apr; 305():115-127. PubMed ID: 28284331
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
    Ohlmeier C; Gothe H; Haas J; Osowski U; Weinhold C; Blauwitz S; Schmedt N; Galetzka W; Berkemeier F; Tackenberg B; Stangel M
    PLoS One; 2020; 15(5):e0231846. PubMed ID: 32357176
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS).
    Mashayekhi F; Hadipour E; Shabani S; Salehi Z
    Clin Neurol Neurosurg; 2024 Feb; 237():108161. PubMed ID: 38325038
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polymorphisms in the Dopaminergic Receptor D3 Gene Correlate with Disease Progression Rate in Relapsing-Remitting Multiple Sclerosis Patients.
    Ferrari M; Vecchio D; D'Alfonso S; Gemma A; Marino F; Comi C; Cosentino M
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927672
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
    Melis M; Littera R; Cocco E; Frau J; Lai S; Congeddu E; Ragatzu P; Serra M; Loi V; Maddi R; Pitzalis R; Orrù S; Chessa L; Perra A; Carcassi C
    PLoS One; 2019; 14(12):e0226615. PubMed ID: 31846493
    [TBL] [Abstract][Full Text] [Related]  

  • 77. T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patients.
    Buhler MM; Bennetts BH; Heard RN; Stewart GJ
    Mult Scler; 2000 Jun; 6(3):140-7. PubMed ID: 10871824
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA profile of the Mexican Mestizo population.
    Arellano J; Vallejo M; Estrada HG; Kretschmer RR
    Tissue Antigens; 1981 Oct; 18(4):242-6. PubMed ID: 7344177
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevated body temperature is linked to fatigue in an Italian sample of relapsing-remitting multiple sclerosis patients.
    Leavitt VM; De Meo E; Riccitelli G; Rocca MA; Comi G; Filippi M; Sumowski JF
    J Neurol; 2015 Nov; 262(11):2440-2. PubMed ID: 26223805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HLA-DR6 association confers increased resistance to T. rubrum onychomycosis in Mexican Mestizos.
    Asz-Sigall D; López-García L; Vega-Memije ME; Lacy-Niebla RM; García-Corona C; Ramírez-Rentería C; Granados J; Villa A; Ameen M; Arenas R
    Int J Dermatol; 2010 Dec; 49(12):1406-9. PubMed ID: 21091674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.